Lipid Infusions to Optimize Nutrition Trial
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT06915441
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Bronchopulmonary Dysplasia
- Neurodevelopmental Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Hours - 28 Weeks
- Healthy Volunteers
- Not accepted
Interventions
- SOLE — DRUGParticipants will first receive LE at 1 g/kg/day, then will advance to 2 g/kg/day and lastly to 3 g/kg/day as tolerated to titrate based on triglyceride level \<250 mg/dL, per clinical team
- MOLE — DRUGParticipants will first receive LE at 1 g/kg/day, then will advance to 2 g/kg/day and lastly to 3 g/kg/day as tolerated to titrate based on triglyceride level \<250 mg/dL, per clinical team
Study Details
The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effective in minimizing pulmonary outcomes, neonatal morbidities, long-term morbidity and mortality, and improving discharge growth and Bayley Scales of Infant Development Fourth Edition (BSID-IV) neurodevelopmental assessment at two years
Key Dates
- Start date
- May 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 30, 2028
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 230 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: SOLE
- Active Comparator: MOLE
Primary Outcome Measure
Number of participants free of BPD (infants breathing in room air) [ Time Frame: 36 weeks post menstrual age (PMA) ]
Central Contacts
- Lindsay F Holzapfel, MD, MS(713) 500-6422
- Emily Stephens(713) 500-5734
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature InfantsPHASE2 · Recruiting · OHB Neonatology Ltd. · Little Rock, Arkansas
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- MRI in BPD SubjectsRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio